calendar
7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k
7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k
Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL
Sponsor: UNICHEM. Form: CAPSULE. Route: ORAL
Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: ASPIRO. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: NOVIMMUNE S.A.. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Product code: SHI. Advisory committee: Dental. Type: Traditional
Product code: SHL. Advisory committee: Ear, Nose, Throat. Type: Direct
Product code: MNS. Advisory committee: Anesthesiology. Type: Traditional
Product code: PMN. Advisory committee: Microbiology. Type: Traditional
Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Special
Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: HRS. Advisory committee: Orthopedic. Type: Traditional
Product code: HRS. Advisory committee: Orthopedic. Type: Traditional
Product code: MBI. Advisory committee: Orthopedic. Type: Traditional
Product code: INI. Advisory committee: Physical Medicine. Type: Traditional
Product code: FKJ. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: QIH. Advisory committee: Radiology. Type: Traditional
Product code: QBC. Advisory committee: Neurology. Type: Traditional
Product code: OLO. Advisory committee: Neurology. Type: Special
Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30
Supplement type: 30-Day Notice. Product code: MAQ. Advisory committee: MI. Decision: OK30
Supplement type: 30-Day Notice. Product code: NJK. Advisory committee: AN. Decision: OK30
Supplement type: 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: OK30
Product code: NPT. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MAQ. Advisory committee: MI. Decision: OK30
Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30
Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30
Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30
Custom Abutment Ti, for Straumann RC, incl. TAN screw; Catalog Number/Art.: 027.4620; — Reason: A material mix-up had occurred during the manufacturing of Straumann¿ Custom Abutments. More specifically, a raw material bar of TAN-material (SAP #701924 / Lot 7130439) was incorrectly identified as a Titanium Bar Ti Gr4 D (SAP #701922 / Lot 7130430). As a result, RC Titanium abutments were manufactured using the TAN Bar material on Mill-from-Bar Machine 396-06. — Status: Ongoing
Custom Abutment AS Ti, for Straumann RC, incl. TAN screw; Catalog Number/Art.: 010.5438; — Reason: A material mix-up had occurred during the manufacturing of Straumann¿ Custom Abutments. More specifically, a raw material bar of TAN-material (SAP #701924 / Lot 7130439) was incorrectly identified as a Titanium Bar Ti Gr4 D (SAP #701922 / Lot 7130430). As a result, RC Titanium abutments were manufactured using the TAN Bar material on Mill-from-Bar Machine 396-06. — Status: Ongoing
HL grant. $29,270. PI: Lillian Hyde
GM grant. $510,183. PI: Yun S Song
NS grant. $744,451. PI: Ruchira Singh
DK grant. $821,618. PI: Steven D Crowley
MH grant. $1,177,156. PI: Thibaut Davy-Mendez
NS grant. $122,769. PI: Yichen Luo
HL grant. $4,750. PI: Lillian Hyde
EB grant. $39,349. PI: Kelly Anne Burke
NS grant. $716,816. PI: Amar Dhand
NS grant. $461,197. PI: David Pitt
NS grant. $632,144. PI: Aaron Mark Gusdon
NS grant. $471,861. PI: David Christopher Martinelli
Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL